# Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk

> **NCT05520684** · — · UNKNOWN · sponsor: **Trabzon Arakli Bayram Halil Public Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Type2diabetes, SGLT2 Inhibitor, Urinary Tract Infection

## Interventions

- **DIAGNOSTIC_TEST:** urine culture and urinalysis

## Key facts

- **NCT ID:** NCT05520684
- **Lead sponsor:** Trabzon Arakli Bayram Halil Public Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520684, "Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05520684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*